AnaptysBio's market cap is currently ―. The company's EPS TTM is $-6.128; its P/E ratio is -3.91; AnaptysBio is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.95. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 7.18M	$ 9.01M	$ 3.32M	$ 3.46M	$ 1.37M
Gross Profit	$ 7.18M	$ 9.01M	$ 3.32M	$ 3.46M	$ 1.37M
EBIT	$ -37.62M	$ -42.22M	$ -37.31M	$ -39.84M	$ -44.26M
EBITDA	$ -37.01M	$ -34.24M	$ -39.71M	$ -41.44M	$ -45.85M
Net Income Common Stockholders	$ -43.94M	$ -42.21M	$ -37.31M	$ -39.84M	$ -44.26M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 354.67M	$ 390.90M	$ 413.05M	$ 429.49M	$ 431.15M
Total Assets	$ 405.83M	$ 452.39M	$ 487.33M	$ 517.10M	$ 549.81M
Total Debt	$ 17.39M	$ 17.81M	$ 18.23M	$ 18.65M	$ 19.06M
Net Debt	$ -337.28M	$ -373.09M	$ -394.81M	$ -410.83M	$ -412.09M
Total Liabilities	$ 358.06M	$ 364.29M	$ 366.94M	$ 368.65M	$ 360.70M
Stockholders Equity	$ 47.78M	$ 88.10M	$ 120.38M	$ 148.45M	$ 191.09M
Cash Flow	-
Free Cash Flow	$ -37.28M	$ -34.63M	$ -36.64M	$ -25.60M	$ -24.74M
Operating Cash Flow	$ -37.25M	$ -34.35M	$ -36.47M	$ -25.41M	$ -24.57M
Investing Cash Flow	$ 68.62M	$ 49.18M	$ 30.64M	$ -20.45M	$ 85.40M
Financing Cash Flow	$ -13.63M	$ -5.16M	$ -3.07M	$ -13.49M	$ -37.57M

Currency in USD

AnaptysBio Earnings and Revenue History

Income Statement >

AnaptysBio Debt to Assets

Balance Sheet >

AnaptysBio Cash Flow

Cash Flow >

AnaptysBio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing